Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -391.90% is 53% below its 5-year average of -256.97%, near the high end of its 5-year range (-4420.33%–73.21%).
68.82% above its 12-month average of -1256.77%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -803.82%.
NET PROFIT MARGIN
-391.90%
NET PROFIT MARGIN AVG TTM
-1256.77%
NET PROFIT MARGIN AVG 3Y
-231.29%
NET PROFIT MARGIN AVG 5Y
-256.97%
NET PROFIT MARGIN AVG 10Y
-227.91%
NET PROFIT MARGIN AVG 15Y
-125.70%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+68.82%
CURRENT VS 3Y AVG
-69.44%
CURRENT VS 5Y AVG
-52.51%
CURRENT VS 10Y AVG
-71.95%
CURRENT VS 15Y AVG
-211.77%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 619 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Arcturus Therapeutics Holdings Inc.
Market Cap
$376.61M
Net Profit Margin
-391.90%
TTM Avg
-1256.77%
3Y Avg
-231.29%
5Y Avg
-256.97%
Market Cap
$378.64M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$381.71M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$383.33M
Net Profit Margin
-7.41%
TTM Avg
-13.48%
3Y Avg
-12.88%
5Y Avg
-9.86%
Market Cap
$370.48M
Net Profit Margin
-81.04%
TTM Avg
-157.37%
3Y Avg
-379.90%
5Y Avg
-317.33%
Market Cap
$357.76M
Net Profit Margin
-1786.27%
TTM Avg
-1435.22%
3Y Avg
-1851.09%
5Y Avg
-9692.20%
Market Cap
$355.08M
Net Profit Margin
8.59%
TTM Avg
7.90%
3Y Avg
10.47%
5Y Avg
19.48%
Market Cap
$354.49M
Net Profit Margin
-184.60%
TTM Avg
-1235.34%
3Y Avg
-1300.41%
5Y Avg
-438.85%
Market Cap
$401.40M
Net Profit Margin
-13.96%
TTM Avg
-29.79%
3Y Avg
-27.76%
5Y Avg
-25.86%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $376.61M | -391.90% | -1256.77% | -231.29% | -256.97% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $378.64M | 0.00% | 0.00% | -102.82% | -175.43% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $381.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Orthofix Medical Inc. (OFIX)vs › | $383.33M | -7.41% | -13.48% | -12.88% | -9.86% |
| Canopy Growth Corporation (CGC)vs › | $370.48M | -81.04% | -157.37% | -379.90% | -317.33% |
| Ocugen, Inc. (OCGN)vs › | $357.76M | -1786.27% | -1435.22% | -1851.09% | -9692.20% |
| Embecta Corp. (EMBC)vs › | $355.08M | 8.59% | 7.90% | 10.47% | 19.48% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $354.49M | -184.60% | -1235.34% | -1300.41% | -438.85% |
| Myriad Genetics, Inc. (MYGN)vs › | $401.40M | -13.96% | -29.79% | -27.76% | -25.86% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $353.28M | -5.49% | -11.37% | -410.78% | -2049.25% |
Operating Margin
-111.5%
Net Profit Margin
-391.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -803.82% |
| 2026-03-31 | -4420.33% |
| 2025-12-31 | -943.82% |
| 2025-09-30 | -78.41% |
| 2025-06-30 | -37.45% |
| 2025-03-31 | -47.91% |
| 2024-12-31 | -142.88% |
| 2024-09-30 | -17.78% |
| 2024-06-30 | -37.45% |
| 2024-03-31 | -82.27% |
| 2023-12-31 | -46.68% |
| 2023-09-30 | -37.40% |
| 2023-06-30 | -499.57% |
| 2023-03-31 | 63.22% |
| 2022-12-31 | 73.21% |
| 2022-09-30 | -263.79% |
| 2022-06-30 | -79.59% |
| 2022-03-31 | -975.76% |
| 2021-12-31 | -667.29% |
| 2021-09-30 | -2219.29% |
| 2021-06-30 | -2727.69% |
| 2021-03-31 | -2649.08% |
| 2020-12-31 | -1389.81% |
| 2020-09-30 | -900.30% |
| 2020-06-30 | -441.99% |
| 2020-03-31 | -369.50% |
| 2019-12-31 | -370.25% |
| 2019-09-30 | -224.02% |
| 2019-06-30 | -6.75% |
| 2019-03-31 | -158.25% |
| 2018-12-31 | -13.34% |
| 2018-09-30 | -124.25% |
| 2018-06-30 | -417.02% |
| 2018-03-31 | -277.61% |
| 2017-12-31 | -8.74% |
| 2017-09-30 | -77.52% |
| 2017-06-30 | -98.14% |
| 2017-03-31 | -91.64% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
